1. Home
  2. GHRS vs MCBS Comparison

GHRS vs MCBS Comparison

Compare GHRS & MCBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GHRS
  • MCBS
  • Stock Information
  • Founded
  • GHRS 2018
  • MCBS 2006
  • Country
  • GHRS Ireland
  • MCBS United States
  • Employees
  • GHRS N/A
  • MCBS N/A
  • Industry
  • GHRS Biotechnology: Pharmaceutical Preparations
  • MCBS Major Banks
  • Sector
  • GHRS Health Care
  • MCBS Finance
  • Exchange
  • GHRS Nasdaq
  • MCBS Nasdaq
  • Market Cap
  • GHRS 849.8M
  • MCBS 745.5M
  • IPO Year
  • GHRS 2021
  • MCBS 2019
  • Fundamental
  • Price
  • GHRS $12.06
  • MCBS $28.69
  • Analyst Decision
  • GHRS Strong Buy
  • MCBS Hold
  • Analyst Count
  • GHRS 8
  • MCBS 1
  • Target Price
  • GHRS $30.63
  • MCBS $34.00
  • AVG Volume (30 Days)
  • GHRS 176.0K
  • MCBS 47.8K
  • Earning Date
  • GHRS 05-08-2025
  • MCBS 07-18-2025
  • Dividend Yield
  • GHRS N/A
  • MCBS 3.24%
  • EPS Growth
  • GHRS N/A
  • MCBS 30.91
  • EPS
  • GHRS N/A
  • MCBS 2.58
  • Revenue
  • GHRS N/A
  • MCBS $143,775,000.00
  • Revenue This Year
  • GHRS N/A
  • MCBS $16.00
  • Revenue Next Year
  • GHRS N/A
  • MCBS $31.75
  • P/E Ratio
  • GHRS N/A
  • MCBS $11.01
  • Revenue Growth
  • GHRS N/A
  • MCBS 19.70
  • 52 Week Low
  • GHRS $6.00
  • MCBS $24.24
  • 52 Week High
  • GHRS $20.50
  • MCBS $36.15
  • Technical
  • Relative Strength Index (RSI)
  • GHRS 52.59
  • MCBS 56.56
  • Support Level
  • GHRS $11.50
  • MCBS $27.73
  • Resistance Level
  • GHRS $12.94
  • MCBS $28.50
  • Average True Range (ATR)
  • GHRS 0.98
  • MCBS 0.50
  • MACD
  • GHRS -0.14
  • MCBS 0.09
  • Stochastic Oscillator
  • GHRS 32.73
  • MCBS 78.87

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

About MCBS MetroCity Bankshares Inc.

MetroCity Bankshares Inc is a holding company of its subsidiary Metro City Bank. It provides commercial banking services such as consumer and commercial checking accounts, savings accounts, certificates of deposits, commercial and consumer loans, money transfers and a variety of other banking services. The banks generate revenue from interest income. Its customers include small business owners, professionals, consumers, and real estate developers.

Share on Social Networks: